Constitutive activation of A3 adenosine receptors by site-directed mutagenesis

被引:38
作者
Chen, A
Gao, ZG
Barak, D
Liang, BT
Jacobson, KA
机构
[1] NIDDKD, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA
[2] Univ Penn, Med Ctr, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA
[3] Univ Penn, Med Ctr, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
purines; G protein-coupled receptor; phospholipase C; adenylyl cyclase; radioligand binding; nucleosides;
D O I
10.1006/bbrc.2001.5027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to create constitutively active mutant human A, adenosine receptors (ARs) using single amino acid replacements, based on findings from other G protein-coupled receptors, A, ARs mutated in transmembrane helical domains (TMs) 1, 3, 6, and 7 were expressed in COS-7 cells and subjected to agonist radioligand binding and phospholipase C (PLC) and adenylyl cyclase (AC) assays. Three mutant receptors, A229E in TM6 and R108A and R108K in the DRY motif of TM3, were found to be constitutively active in both functional assays. The potency of the A, agonist CI-IB-MECA (1-chloro-N-6-(3-iodobenzyl)adenosine-5'-N-methyluronamide) in PLC activation was enhanced by at least an order of magnitude over wild type (EC50 951 nM) in R108A and A229E mutant receptors. CI-IB-MECA was much less potent (>10-fold) in C88F, Y109F, and Y282F and mutants or inactive following double mutation of the DRY motif. The degree of constitutive activation was more pronounced for the AC signaling pathway than for the PLC signaling pathway. The results indicated that specific locations within the TMs proximal to the cytosolic region were responsible for constraining the receptor in a G protein-uncoupled conformation. (C) 2001 Academic Press.
引用
收藏
页码:596 / 601
页数:6
相关论文
共 37 条
[1]  
Alewijnse AE, 2000, MOL PHARMACOL, V57, P890
[2]   Constitutively signaling G-protein-coupled receptors and human disease [J].
Arvanitakis, L ;
Geras-Raaka, E ;
Gershengorn, MC .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1998, 9 (01) :27-31
[3]   Constitutive activation of the δ opioid receptor by mutations in transmembrane domains III and VII [J].
Befort, K ;
Zilliox, C ;
Filliol, D ;
Yue, SY ;
Kieffer, BL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18574-18581
[4]   CHANGES IN THE LEVELS OF INOSITOL PHOSPHATES AFTER AGONIST-DEPENDENT HYDROLYSIS OF MEMBRANE PHOSPHOINOSITIDES [J].
BERRIDGE, MJ ;
DAWSON, RMC ;
DOWNES, CP ;
HESLOP, JP ;
IRVINE, RF .
BIOCHEMICAL JOURNAL, 1983, 212 (02) :473-482
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   STRUCTURE-FUNCTION OF MUSCARINIC RECEPTOR COUPLING TO G-PROTEINS - RANDOM SATURATION MUTAGENESIS IDENTIFIES A CRITICAL DETERMINANT OF RECEPTOR AFFINITY FOR G-PROTEINS [J].
BURSTEIN, ES ;
SPALDING, TA ;
HILLEUBANKS, D ;
BRANN, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (07) :3141-3146
[7]   ANTAGONISTS WITH NEGATIVE INTRINSIC ACTIVITY AT DELTA-OPIOID RECEPTORS COUPLED TO GTP-BINDING PROTEINS [J].
COSTA, T ;
HERZ, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (19) :7321-7325
[8]  
CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
[9]  
DELEAN A, 1980, J BIOL CHEM, V255, P7108
[10]   ISCHEMIC PRECONDITIONING - NATURES OWN CARDIOPROTECTIVE INTERVENTION [J].
DOWNEY, JM .
TRENDS IN CARDIOVASCULAR MEDICINE, 1992, 2 (05) :170-176